Towards a life free from cancer

Learn more

This is Curacell

Curacell develops cell based immunotherapies for cancer treatment focusing on TILs (Tumor Infiltrating Lymphocytes), an investigational therapy aimed at a durable cure for solid tumor cancers.

The company is initiating its first clinical program targeting indications with high prevalence and the potential to make a significant impact on cancer patients worldwide.

Learn More

Our science

TILs are a natural immune response to cancer. Curacell’s treatment is an autologous cell therapy built on a proprietary manufacturing process. It also involves a unique pre-regiment of patients and combination with other innovative cancer therapies.

Promising results from our scientific team members lay a strong foundation for Curacell’s next clinical stage.

Learn more


Our team is growing at a high pace and we are always looking for new talent.

Do you want to make an impact for cancer patients? Are you ready for a new challenge? Please don't hesitate to reach out to us.

Learn more